NEW YORK, July 24 /Xinhua-PRNewswire-FirstCall/ -- China Dongsheng International, Inc. (OTC:CDSG.OB) (BULLETIN BOARD: CDSG.OB) (the "Company") announced today that Dongsheng Weiye Science and Technology Co. Ltd., the Company's wholly owned China-based operating subsidiary in the province of Jilin, has obtained provincial-level approvals to engage in direct sales within sixteen provinces and autonomous regions across China. Dongsheng Weiye has also completed the filing of all required application materials for the National Direct Marketing License. Under Chinese law, all companies intending to engage in direct sales marketing are required to have at least 80 million RMB (approximately $10.5 million USD) in registered capital, and to set aside an additional 20 million RMB (approximately $2.6 million USD) with China's Ministry of Commerce for collateral risk control. Due to the high barrier to entry into the direct selling industry, only twelve companies currently hold the National Direct Marketing License. "We are excited at the prospect of becoming the first company in Jilin Province, to receive the approval from the Ministry of Commerce", commented Mr. Aidong Yu, the Company's Chairman and President. "Obtaining the National Direct Marketing License will be a major milestone in the development of Dongsheng, attesting to the viability of our business model. With the National License, we will be even more confident in our approach toward creating increased value for our customers and shareholders at home and abroad." About China Dongsheng International, Inc. China Dongsheng International, Inc., through its 100%-owned subsidiary, Jilin Dongsheng Weiye Science and Technology Co., Ltd, is engaged in the development and manufacture of nutritional supplements and personal care products domestically in China. It sells these products through a network marketing system with approximately 200,000 distributors and 2,500 retail outlets in twenty-six provinces throughout China. Safe Harbor Statement The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. Contact DATASOURCE: China Dongsheng International, Inc. CONTACT: Peter D. Zhou, China DongSheng International, Inc., +1-212-232-0120

Copyright